Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

被引：0
|
作者：
M Elle Saine
Dena M Carbonari
Craig W Newcomb
Melissa S Nezamzadeh
Kevin Haynes
Jason A Roy
Serena Cardillo
Sean Hennessy
Crystal N Holick
Daina B Esposito
Arlene M Gallagher
Harshvinder Bhullar
Brian L Strom
Vincent Lo Re
机构：
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics
[2] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology, Center for Pharmacoepidemiology Research and Training
[3] HealthCore,Department of Medicine
[4] Inc,Rutgers Biomedical & Health Sciences
[5] Perelman School of Medicine at the University of Pennsylvania,undefined
[6] Clinical Practice Research Datalink,undefined
[7] Medicines and Healthcare Products Regulatory Agency,undefined
[8] Cegedim Strategic Data Medical Research,undefined
[9] Rutgers,undefined
[10] the State University of New Jersey,undefined
来源：
BMC Pharmacology and Toxicology | / 16卷
关键词：
Diabetes mellitus; Saxagliptin; Dipeptidyl peptidase IV inhibitor; Pharmacoepidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs
    Saine, M. Elle
    Carbonari, Dena M.
    Newcomb, Craig W.
    Nezamzadeh, Melissa S.
    Haynes, Kevin
    Roy, Jason A.
    Cardillo, Serena
    Hennessy, Sean
    Holick, Crystal N.
    Esposito, Daina B.
    Gallagher, Arlene M.
    Bhullar, Harshvinder
    Strom, Brian L.
    Lo Re, Vincent, III
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
  • [2] Oral anti-diabetic drugs for the prevention of Type 2 diabetes
    Phung, O. J.
    Sood, N. A.
    Sill, B. E.
    Coleman, C. I.
    [J]. DIABETIC MEDICINE, 2011, 28 (08) : 948 - 964
  • [3] C-peptide Level in Patients With Uncontrolled Type 2 Diabetes Mellitus on Oral Anti-diabetic Drugs
    Arya, Purnendu
    Husain, Noor
    Kumar, Chakrapani
    Shekhar, Ravi
    Prakash, Ved
    Hameed, Saajid
    Mohan, Lalit
    Dikshit, Harihar
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [4] MEASUREMENT OF HRQOL USING EQ-5D IN TYPE 2 DIABETES MELLITUS PATIENTS TREATED WITH ORAL ANTI-DIABETIC DRUGS IN CHINA
    Li, H. C.
    Chang, J. H.
    Liu, G. G.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A296 - A297
  • [5] Anti-diabetic drugs and weight loss in patients with type 2 diabetes
    Lazzaroni, Elisa
    Ben Nasr, Moufida
    Loretelli, Cristian
    Pastore, Ida
    Plebani, Laura
    Lunati, Maria Elena
    Vallone, Luciana
    Bolla, Andrea Mario
    Rossi, Antonio
    Montefusco, Laura
    Ippolito, Elio
    Berra, Cesare
    D'Addio, Francesca
    Zuccotti, Gian Vincenzo
    Fiorina, Paolo
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 171
  • [6] Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales
    Datta-Nemdharry, Preeti
    Thomson, Andrew
    Beynon, Julie
    Donegan, Katherine
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (02) : 127 - 135
  • [7] Effects of Two Different Oral Anti Diabetic Drugs in Type 2 Diabetes Mellitus Patients
    Chohan, Raj Kumar
    Waseem, Rizwan
    Bashir, Aamir
    Murad, Shah
    Qamar, Samina
    Ghurbakhshani, Amar Lal
    Sheikh, Riaz Ahmad
    Ashraf, Hafiz Hamad
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (02): : 330 - +
  • [8] Trends and Determinants of Oral Anti-Diabetic Initiation in Youth with Suspected Type 2 Diabetes
    Cai, Mona
    Kappelman, Michael D.
    Girman, Cynthia J.
    Jain, Nina
    Stuermer, Til
    Brookhart, Maurice Alan
    [J]. PLOS ONE, 2015, 10 (10):
  • [9] Compared to Depressive Symptoms of Type 2 Diabetic Patients Who were Treated with Oral Anti-Diabetic Drugs and Insulin
    Isik, Nurten A.
    Buzlu, Sevim
    [J]. GAZI MEDICAL JOURNAL, 2016, 27 (04): : 189 - 192
  • [10] Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
    Dimnjakovic, Jelena
    Buble, Tamara
    Ivanko, Pero
    Pristas, Ivan
    Brborovic, Ognjen
    Brborovic, Hana
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
12345